Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

W. L. GORE & ASSOCIATES, INC

US

Last updated September 17, 2026

Information

Country
US
Address
1505 NORTH FOURTH ST., FLAGSTAFF, AZ, 86004
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
2017233
DUNS Number
—

Catalogue (1343)

Page 15 of 27
DeviceModel / ReferenceRegistriesClassStatus
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis ATAA43120160A
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft SRRT08030070L
FDA UDI
Class IIActive
GORE EXCLUDER AAA Endoprosthesis with C3 Delivery RMT261418
FDA UDI
Class IIIUnknown
GORE SEAMGUARD Bioabsorbable Staple Line Reinforce BSGEC60AAC
FDA UDI
Class IIActive
GORE HELEX Septal Occluder HX2025
FDA UDI
Class IIIUnknown
GORE-TEX Suture 8J02
FDA UDI
Class IIActive
GORE PROPATEN Vascular Graft HT066080A
FDA UDI
Class IIActive
GORE PRECLUDE MVP Dura Substitute 1MVP402
FDA UDI
Class IIUnknown
GORE MYCROMESH PLUS Biomaterial 1MYMP06
FDA UDI
Class IIUnknown
GORE® DrySeal Flex Introducer Sheath GDSF1033
FDA UDI
Class IIActive
GORE INTERING Vascular Graft IRST07040040L
FDA UDI
Class IIActive
GORE TAG Thoracic Endoprosthesis TGT3710
FDA UDI
Class IIIUnknown
GORE VIABAHN VBX Balloon Expandable Endo BXAL085901A
FDA UDI
Class IIIActive
GORE PRECLUDE Pericardial Membrane 1PCM103
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis with Heparin VBH101002
FDA UDI
Class IIIActive
GORE VIABAHN Endoprosthesis with Heparin VBJR062502A
FDA UDI
Class IIIActive
GORE EXCLUDER AAA Endoprosthesis with C3 Delivery RLT311413
FDA UDI
Class IIIActive
GORE VIABAHN VBX Balloon Expandable Endo BXB071902A
FDA UDI
Class IIIActive
GORE EXCLUDER AAA Endoprosthesis PLC121000
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft SRRT06030070L
FDA UDI
Class IIActive
GORE-TEX Soft Tissue Patch 1320030020
FDA UDI
Class IIActive
GORE PROPATEN Vascular Graft IRTH068080A
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis with Heparin VBJ061502
FDA UDI
Class IIIUnknown
GORE-TEX Stretch Vascular Graft-Bifurcated SBT1201D
FDA UDI
Class IIActive
GORE EXCLUDER AAA Endoprosthesis with C3 Delivery RMT261416
FDA UDI
Class IIIUnknown
GORE-TEX Vascular Graft V10080L
FDA UDI
Class IIUnknown
GORE PRECLUDE PDX Dura Substitute 1PDX307
FDA UDI
Class IIUnknown
GORE VIABAHN VBX Balloon Expandable Endo BXB067901A
FDA UDI
Class IIIActive
TIGRIS Vascular Stent PHA050802A
FDA UDI
Class IIIUnknown
GORE ENFORM Intraperitoneal Biomaterial GBFR2025
FDA UDI
Class IIActive
GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral CXT231412
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft RRT06080100L
FDA UDI
Class IIUnknown
GORE PROPATEN Vascular Graft HT057090A
FDA UDI
Class IIActive
GORE VIABAHN VBX Balloon Expandable Endo BXA071502A
FDA UDI
Class IIIActive
GORE-TEX Stretch Vascular Graft S0609
FDA UDI
Class IIActive
GORE EXCLUDER AAA Endoprosthesis PXC141000
FDA UDI
Class IIIActive
GORE VIABAHN Endoprosthesis with Heparin VBH091002A
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft RRT07070070L
FDA UDI
Class IIActive
Gore® Dualmesh® Plus Biomaterial Holes 1DLMCPH02
FDA UDI
Class IIUnknown
GORE EXCLUDER AAA Endoprosthesis PXT311415
FDA UDI
Class IIIUnknown
GORE EXCLUDER AAA Endoprosthesis with C3 Delivery RLT231418
FDA UDI
Class IIIActive
GORE ACUSEAL Vascular Graft ECH470045A
FDA UDI
Class IIActive
GORE TAG Conformable Thoracic Stent Graft TGMR373710
FDA UDI
Class IIIActive
GORE VIABAHN VBX Balloon Expandable Endo BXA067902A
FDA UDI
Class IIIActive
GORE EXCLUDER AAA Endoprosthesis PLA280300
FDA UDI
Class IIIActive
GORE-TEX Stretch Vascular Graft SA1403
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis with Heparin VBJ070202
FDA UDI
Class IIIActive
GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral CXT261412
FDA UDI
Class IIIActive
GORE-TEX Stretch Vascular Graft S47048
FDA UDI
Class IIActive
GORE-TEX Vascular Graft RRT08030070L
FDA UDI
Class IIUnknown

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (28)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Aug 26, 2025Z-0036-2026—open, classified

Reports of vascular graft delamination, which may lead to reduced access flow; cannulation difficulties; bleeding or bruising; and harms related to reintervention procedures, so Instructions for Use will be updated to modify existing warning to 1) further clarify techniques that may contribute to the risk of delamination, 2) Addition of delamination to device-related adverse event section.

Jul 3, 2024Z-2513-2024—open, classified

Devices were labeled with an expiration date of four years and ten days rather than the validated two years.

Jul 1, 2024Z-2946-2024—open, classified

Due to packaging defects, sterility assurance and heparin activity may be compromised.

Jul 1, 2024Z-2945-2024—open, classified

Due to packaging defects, sterility assurance and heparin activity may be compromised.

Jan 19, 2024Z-1179-2024—open, classified

Devices without transmural drainage holes may be mislabeled as devices with transmural drainage holes, or vice versa. Potential health impact includes extending procedure time, unplanned device removal, secondary procedure, cholangitis, cholecystitis, and/or pain. The GORE VIABIL Short Wire Biliary Endoprosthesis is a flexible, self-expanding endoprosthesis designed to maintain luminal patency of the common bile duct which may be obstructed. The endoprosthesis is radially compressed and secured onto the distal end of a catheter-based delivery system for deployment. The catheter provides a means for accessing and implanting the GORE VIABIL Short Wire Biliary Endoprosthesis at the target site in the biliary tract.

Dec 14, 2022Z-1048-2023—open, classified

Septal Occluders released with incomplete quality test documentation that assesses the release of the device from the delivery system during the index procedure. A potential failure of this quality test could potentially result could result in occluder embolization, anoxic brain injury, central venous or arterial perforation or rupture.

Sep 21, 2022Z-0136-2023—open, classified

Due to manufacturing records (Release Test Results) indicating "Failed".

Sep 7, 2021Z-0077-2022—open, classified

Incorrect labeling, specifically, expandable endoprosthesis labeled as 8 mm x 59mm x 135 cm, however may contain a 9mm x 29 mm x 135 cm device.

Sep 2, 2021Z-0171-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0168-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0169-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0165-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0170-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0164-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0172-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0166-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0167-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Jul 12, 2021Z-2340-2021—open, classified

Complaints received concerning Balloon Catheter leakage from the guidewire lumen and the y-hub during preparation resulting in either insufficient inflation or an inability to inflate.

May 12, 2021Z-2293-2021—open, classified

Vascular Grafts containing an inner diameter of 6 mm may be incorrectly labeled as 5 mm and Vascular Grafts containing an inner diameter of 5 mm are incorrectly labeled as 6 mm.

May 12, 2021Z-2292-2021—open, classified

Vascular Grafts containing an inner diameter of 6 mm may be incorrectly labeled as 5 mm and Vascular Grafts containing an inner diameter of 5 mm are incorrectly labeled as 6 mm.

Apr 5, 2021Z-1593-2021—terminated

The Gore post market surveillance team received a complaint that a GORE VIABIL Biliary Endoprosthesis appeared shorter than the labeled length.

Sep 9, 2020Z-0290-2021—open, classified

Due to secondary deployment fiber being attached to secondary deployment handle, completion of deployment via the deployment line access hatch was not possible

Sep 9, 2020Z-0291-2021—open, classified

When the delivery catheter was attempted to be removed, there was an observed connection between the stent graft and the delivery catheter that prevented the delivery catheter from being withdrawn.

Jan 6, 2020Z-0996-2020—terminated

Firm has received reports of leading end catheter component separations.

Jan 6, 2020Z-0995-2020—terminated

Firm has received reports of leading end catheter component separations.

Dec 17, 2019Z-2052-2020—terminated

The incorrect label was placed on both the primary and secondary package.

Nov 18, 2019Z-1962-2020—terminated

The devices were mislabeled with the incorrect product size resulting in 16Fr devices being labeled as 14Fr devices.

Sep 25, 2017Z-0048-2018—terminated

Incomplete and/or partial deployment of the CTAG Device during the endovascular procedure.